Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-079537
Filing Date
2024-07-12
Accepted
2024-07-12 16:06:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 tm2419225d2_424b3.htm 424B3 183312
2 GRAPHIC tm2419225d2_424b3img01.jpg GRAPHIC 11595
3 GRAPHIC tm2419225d2_424b3img02.jpg GRAPHIC 24420
  Complete submission text file 0001104659-24-079537.txt   234243
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267328 | Film No.: 241114520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)